Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial
Phase 3 TRIUMPH-1 trial data show retatrutide reduced the AHI by up to 36.1 events per hour alongside substantial weight loss.
Latest Sleep News
Editor's Picks
Wesper Demos Two Levels of Sleep Testing (in One Ecosystem)
The new platform integrates Wesper Lab and Wesper Lite to offer customized diagnostic pathways and streamline patient management for sleep clinics.
Your Go-To Resource for the Sleep Medicine Field
Stay informed with the latest sleep research, clinical guidelines, product innovations, and industry news — all in one curated update.Comparison Guides
Comparison Guides
CPAP Pillows Comparison Guide
This chart highlights key specifications and features among CPAP pillows, including adjustability, dimensions, materials, washability, and price.
Continuing Education
Continuing Education
Holistic & Patient-Centered Sleep Care: Earn Continuing Education
This CSTE quiz covers biopsychosocial approaches to sleep health, innovative uses of home sleep testing for therapy monitoring, and updated perspectives on restless legs syndrome.
Holistic Perspectives
New Toolkit Helps Clinicians Integrate Lifestyle Interventions with Obesity Medications
The American College of Lifestyle Medicine released a toolkit providing guidance and patient education for pairing obesity medications like GLP-1s with lifestyle care.
Diagnostic Tools & Techniques
OxiWear Secures Payor Coverage for Continuous Oxygen Measuring Wearable
The expanded reimbursement access aims to make the FDA-cleared device more affordable for patients with conditions linked to hypoxia.
Treatment Modalities
The Business of Sleep Medicine
Sleep Tech Shortage Survival Guide
From growing your own talent to outsourcing scoring, sleep lab leaders share practical strategies to stabilize staffing in a shrinking workforce.
